(See also Overview of Transplantation.)
Heart transplantation is reserved for people who have one of the following disorders if the disorder cannot be treated effectively with drugs or other forms of surgery:
Heart transplantation alone cannot be done if people have severe pulmonary hypertension (high blood pressure in the arteries of the lungs) that has not responded to drug treatment. These people would likely be candidates for combined heart-lung transplantation.
In some medical centers, heart machines can keep people alive for weeks or months until a compatible heart can be found. Also, newly developed, implantable artificial hearts (called ventricular assist devices or VADs) that pump blood to the rest of the body are being used to tide people over until a heart is available or are used in people who are not candidates for heart transplantation. Because these devices have been greatly improved, they are increasingly being used as a long-term replacement. As a result, the need for heart transplantation has somewhat decreased.
About 95% of people who have had a heart transplant are substantially better able to exercise and do daily activities than they were before the transplantation. Over 70% return to full-time employment. About 85 to 90% of heart transplant recipients survive for at least 1 year.
Through an incision in the chest, most of the damaged heart is removed, but the back wall of one of the upper heart chambers (atria) is left. The donated heart is then attached to what remains of the recipient’s heart.
Heart transplantation takes about 3 to 5 hours. The hospital stay after this operation is usually 7 to 14 days.
Drugs to inhibit the immune system (immunosuppressants), including corticosteroids, are started the day of transplantation. These drugs can help reduce the risk that the recipient will reject the transplanted heart.
Transplantation can cause various complications.
Most deaths that occur after heart transplantation are due to rejection soon after the operation or to infections.
Immunosuppressants must be taken to prevent rejection of a transplanted heart.
Rejection, if it occurs, may cause weakness and a rapid or other abnormal heart rhythm. When rejection occurs, the transplanted heart may not function well, causing low blood pressure and accumulation of fluid in the legs and sometimes the abdomen, resulting in swelling—a condition called edema. Fluid may also accumulate in the lungs, causing difficulty breathing. However, rejection is often mild. In such cases, no symptoms may occur, but electrocardiography (ECG) may detect changes in the heart’s electrical activity.
If doctors suspect rejection, they usually do a biopsy. A catheter is inserted through an incision in the neck into a vein and is threaded to the heart. A device at the end of the catheter is used to remove a small piece of heart tissue, which is examined under a microscope. Because effects of rejection can be serious, doctors also routinely do a biopsy once a year to look for rejection that has not yet caused symptoms.
About one fourth of people who have a heart transplant develop atherosclerosis in the coronary arteries.
Treatment includes drugs to lower lipid (fat) levels in the blood and diltiazem (a drug that can help prevent blood vessels from narrowing).
Drugs Mentioned In This Article
|Generic Name||Select Brand Names|
|CARDIZEM, CARTIA XT, DILACOR XR|